Search

everythinglearnresearchcommunity

for

Search:↓

The N-K GM Series offers a new method to reduce aflatoxin poisoning and cancer, improving health and saving costs in affected regions.

Overexpressing NSD3 in mice causes breast cancer-like tumors and gland abnormalities.

Patients with Alopecia areata have fewer specific immune cells that normally regulate the immune system, which may contribute to the condition.

Combining specific nanoparticles with immune therapy significantly improves cancer treatment.

Targeting vitamin D and androgen receptors may effectively treat triple-negative breast cancer, especially with chemotherapy.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

Nucleic acids trigger chemokine production in skin cells, affecting skin inflammation.

Arg1+ macrophages may play a role in Alopecia Areata, offering new treatment targets.

Lack of functional CYLD in mice leads to early aging and cancer.

Surgery and antifungal medication are effective for treating Merkel cell carcinoma with fungal infection.

A PIK3CA mutation in Schwann cells causes severe nerve damage and increased glycolysis, but early treatment can help.

Imatinib can repigment grey hair, while SU11428 can cause temporary hair depigmentation.

Inhibiting PDE8A may help treat hair loss by boosting fat cell growth and hair regeneration.

Cancer treatments often cause skin, nail, and hair problems.

Certain microRNAs may help treat alopecia areata by targeting immune pathways.

INTASYL is a promising, adaptable RNAi technology for treating skin cancers.

IL-1 and IL-7 help activate cells that boost hair follicle stem cell growth, aiding wound healing.

T cells affect skin cell genes in inflammatory diseases, and therapy can normalize these changes.

Combining UVB irradiation and anti-CD154 antibody improves hair follicle transplant survival.

CD4+ skin cells may be precursors to basal cell carcinoma.

Jagged-1 in skin Tregs is crucial for timely wound healing by recruiting specific immune cells.

Corticosteroid therapy reduces specific immune cells and promotes hair growth in alopecia areata patients.

Vaccines and targeting TrxR variants can help prevent cancer and reduce metastasis.

Certain KIR genes in Indian SLE patients are linked to disease severity and could be biomarkers.

FTY720 helps transplanted fat survive better by reducing immune rejection and improving blood vessel growth.

Genetic mutation and carcinogen treatment are both needed for skin cancer to develop in these specific mice.

PD‐L1 and PD‐L2 may not effectively control immune activation in alopecia areata.

CD19-CAR T cell therapy may help regenerate skin in systemic sclerosis.

Ku80 is a key receptor for Thymosin β4, affecting cell migration and wound healing.